• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.淀粉样变性患者接种BNT162b2疫苗后抗SARS-CoV-2中和抗体的产生动力学及治疗的影响
Am J Hematol. 2022 Jan 1;97(1):E27-E31. doi: 10.1002/ajh.26406. Epub 2021 Nov 23.
2
Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.在接受过大量治疗的多发性骨髓瘤和AL淀粉样变性患者中，抗SARS-CoV-2疫苗接种后体液免疫反应减弱。
Am J Hematol. 2021 Dec 1;96(12):E475-E478. doi: 10.1002/ajh.26373. Epub 2021 Oct 16.
3
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.接种疫苗后血清中针对新冠病毒变异株中和抗体的快速检测
J Mol Cell Biol. 2022 Jan 29;13(12):918-920. doi: 10.1093/jmcb/mjab050.
4
Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination.BNT162b2 mRNA新冠疫苗接种后糖尿病和非糖尿病个体均产生强劲抗体水平。
Front Immunol. 2021 Nov 24;12:752233. doi: 10.3389/fimmu.2021.752233. eCollection 2021.
5
Distinct neutralization profile of spike variants by antibodies induced upon SARS-CoV-2 infection or vaccination.SARS-CoV-2感染或疫苗接种诱导产生的抗体对刺突蛋白变体的独特中和谱。
Am J Hematol. 2022 Jan 1;97(1):E3-E7. doi: 10.1002/ajh.26380. Epub 2021 Nov 5.
6
Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical Study.自身免疫性甲状腺炎患者对 COVID-19 BNT162b2 mRNA 疫苗的免疫反应与健康受试者相似，而接种疫苗可能会影响甲状腺功能：一项临床研究。
Front Endocrinol (Lausanne). 2022 Feb 22;13:840668. doi: 10.3389/fendo.2022.840668. eCollection 2022.
7
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性。
Br J Haematol. 2022 Feb;196(4):884-891. doi: 10.1111/bjh.17918. Epub 2021 Oct 28.
8
Serological response following BNT162b2 anti-SARS-CoV-2 mRNA vaccination in haematopoietic stem cell transplantation patients.造血干细胞移植患者接种BNT162b2抗SARS-CoV-2 mRNA疫苗后的血清学反应。
Br J Haematol. 2022 Feb;196(4):928-931. doi: 10.1111/bjh.17873. Epub 2021 Oct 18.
9
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.意大利出现的新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）B.1.621谱系集群以及病毒分离株对BNT162b2疫苗的敏感性。
J Med Virol. 2021 Dec;93(12):6468-6470. doi: 10.1002/jmv.27247. Epub 2021 Aug 10.
10
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2.接种BNT162b2疫苗后不同血液系统癌症中抗SARS-CoV-2抗体的12周动力学
Br J Haematol. 2022 Jan;196(2):362-367. doi: 10.1111/bjh.17821. Epub 2021 Sep 6.

引用本文的文献

1
COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?新型冠状病毒肺炎感染与疫苗接种及其与淀粉样变性的关系：我们目前了解多少？
Vaccines (Basel). 2023 Jun 24;11(7):1139. doi: 10.3390/vaccines11071139.
2
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.接种 BNT162b2 mRNA 疫苗的血液恶性肿瘤移植患者体内 SARS-CoV-2 抗体和固有细胞因子减少。
Front Immunol. 2022 May 25;13:899972. doi: 10.3389/fimmu.2022.899972. eCollection 2022.
3
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition.接受免疫检查点抑制治疗的癌症患者接种疫苗后SARS-CoV-2中和抗体的动力学
Cancers (Basel). 2022 Jun 4;14(11):2796. doi: 10.3390/cancers14112796.
4
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis.系统性轻链（AL）淀粉样变性患者第二次接种新冠病毒疫苗后的血清转化率
Hemasphere. 2022 Feb 15;6(3):e688. doi: 10.1097/HS9.0000000000000688. eCollection 2022 Mar.

Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

作者信息

Kastritis Efstathios, Terpos Evangelos, Evangelakou Zoi, Theodorakakou Foteini, Fotiou Despina, Manola Maria S, Gianniou Despoina D, Bagratuni Tina, Kanellias Nikolaos, Migkou Magdalini, Gavriatopoulou Maria, Trougakos Ioannis P, Dimopoulos Meletios A

机构信息

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Am J Hematol. 2022 Jan 1;97(1):E27-E31. doi: 10.1002/ajh.26406. Epub 2021 Nov 23.

DOI:10.1002/ajh.26406
PMID:34778995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8646930/
Abstract
摘要